Victoria Magrioti

2.3k total citations · 1 hit paper
42 papers, 1.9k citations indexed

About

Victoria Magrioti is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Victoria Magrioti has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Victoria Magrioti's work include Protein Kinase Regulation and GTPase Signaling (16 papers), Sphingolipid Metabolism and Signaling (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Victoria Magrioti is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (16 papers), Sphingolipid Metabolism and Signaling (5 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Victoria Magrioti collaborates with scholars based in Greece, United States and France. Victoria Magrioti's co-authors include George Kokotos, Edward A. Dennis, Yuan‐Hao Hsu, Jian Cao, Violetta Constantinou‐Kokotou, Efrosini Barbayianni, Daren Stephens, Constantinos Baskakis, Panagiota Moutevelis‐Minakakis and John E. Burke and has published in prestigious journals such as Chemical Reviews, The Journal of Immunology and PLoS ONE.

In The Last Decade

Victoria Magrioti

41 papers receiving 1.9k citations

Hit Papers

Phospholipase A2Enzymes: Physical Structure, Biological F... 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Magrioti Greece 18 1.1k 301 262 239 226 42 1.9k
Yuan‐Hao Hsu Taiwan 17 970 0.9× 113 0.4× 225 0.9× 133 0.6× 212 0.9× 39 1.6k
Ganesha Rai United States 26 1.3k 1.2× 311 1.0× 137 0.5× 151 0.6× 140 0.6× 90 2.2k
Futoshi Nara Japan 21 1.0k 0.9× 213 0.7× 212 0.8× 130 0.5× 69 0.3× 48 1.5k
Mauro Salvi Italy 31 2.3k 2.1× 120 0.4× 153 0.6× 157 0.7× 214 0.9× 94 3.1k
Michelle F. Browner United States 28 1.6k 1.5× 643 2.1× 301 1.1× 635 2.7× 270 1.2× 41 3.2k
Curtis L. Ashendel United States 25 2.1k 1.9× 185 0.6× 154 0.6× 204 0.9× 219 1.0× 52 3.0k
Verónique Noé Spain 30 1.8k 1.6× 157 0.5× 192 0.7× 91 0.4× 86 0.4× 109 2.8k
Yi Huang United States 37 3.0k 2.7× 143 0.5× 352 1.3× 233 1.0× 256 1.1× 87 4.0k
Wanda Cromlish Canada 25 925 0.8× 392 1.3× 332 1.3× 722 3.0× 220 1.0× 34 2.1k
Kilian W. Conde‐Frieboes Denmark 18 960 0.9× 258 0.9× 75 0.3× 90 0.4× 107 0.5× 33 1.4k

Countries citing papers authored by Victoria Magrioti

Since Specialization
Citations

This map shows the geographic impact of Victoria Magrioti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Magrioti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Magrioti more than expected).

Fields of papers citing papers by Victoria Magrioti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Magrioti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Magrioti. The network helps show where Victoria Magrioti may publish in the future.

Co-authorship network of co-authors of Victoria Magrioti

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Magrioti. A scholar is included among the top collaborators of Victoria Magrioti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Magrioti. Victoria Magrioti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poncin, Isabelle, et al.. (2022). Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives. Bioorganic & Medicinal Chemistry Letters. 64. 128692–128692. 8 indexed citations
2.
Santucci, Pierre, et al.. (2019). Synthesis of Long‐Chain β‐Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria. ChemMedChem. 14(3). 349–358. 9 indexed citations
3.
Magrioti, Victoria, et al.. (2019). Synthesis of pentafluorobenzene-based NHC adducts and their catalytic activity in the microwave-assisted reactions of aldehydes. Tetrahedron Letters. 61(4). 151419–151419. 7 indexed citations
4.
Kokotou, Maroula G., Victoria Magrioti, Efrosini Barbayianni, et al.. (2017). 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2. Scientific Reports. 7(1). 7025–7025. 13 indexed citations
5.
Magrioti, Victoria, Maroula G. Kokotou, Aikaterini Nikolaou, et al.. (2016). 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity. Bioorganic & Medicinal Chemistry. 24(19). 4544–4554. 5 indexed citations
6.
Vasilakaki, Sofia, Efrosini Barbayianni, Victoria Magrioti, et al.. (2016). Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells. Bioorganic & Medicinal Chemistry. 24(13). 3029–3034. 11 indexed citations
7.
Bone, Robert N., Victoria Magrioti, Maroula G. Kokotou, et al.. (2014). Inhibition of Ca2+-Independent Phospholipase A2β (iPLA2β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice. Diabetes. 64(2). 541–554. 38 indexed citations
8.
Kokotos, George, Astrid Jullumstrø Feuerherm, Efrosini Barbayianni, et al.. (2014). Inhibition of Group IVA Cytosolic Phospholipase A2 by Thiazolyl Ketones in Vitro, ex Vivo, and in Vivo. Journal of Medicinal Chemistry. 57(18). 7523–7535. 35 indexed citations
9.
Barbayianni, Efrosini, Victoria Magrioti, Panagiota Moutevelis‐Minakakis, & George Kokotos. (2013). Autotaxin inhibitors: a patent review. Expert Opinion on Therapeutic Patents. 23(9). 1123–1132. 54 indexed citations
10.
Ali, Tomader, George Kokotos, Victoria Magrioti, et al.. (2013). Characterization of FKGK18 as Inhibitor of Group VIA Ca2+-Independent Phospholipase A2 (iPLA2β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes. PLoS ONE. 8(8). e71748–e71748. 30 indexed citations
11.
Mouchlis, Varnavas D., Victoria Magrioti, Efrosini Barbayianni, et al.. (2010). Inhibition of secreted phospholipases A2 by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations. Bioorganic & Medicinal Chemistry. 19(2). 735–743. 28 indexed citations
12.
Barbayianni, Efrosini, Daren Stephens, Victoria Magrioti, et al.. (2009). 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides. Bioorganic & Medicinal Chemistry. 17(13). 4833–4843. 18 indexed citations
13.
Baskakis, Constantinos, Victoria Magrioti, Violetta Constantinou‐Kokotou, et al.. (2009). Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain. 132(5). 1221–1235. 82 indexed citations
14.
Magrioti, Victoria, et al.. (2008). A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters. 18(20). 5424–5427. 7 indexed citations
15.
Magrioti, Victoria, et al.. (2008). Synthesis of 2‐oxoamides based on sulfonamide analogs of γ‐amino acids and their activity on phospholipase A2. Journal of Peptide Science. 14(10). 1111–1120. 7 indexed citations
16.
Six, David A., Efrosini Barbayianni, Violetta Constantinou‐Kokotou, et al.. (2007). Structure−Activity Relationship of 2-Oxoamide Inhibition of Group IVA Cytosolic Phospholipase A2and Group V Secreted Phospholipase A2. Journal of Medicinal Chemistry. 50(17). 4222–4235. 62 indexed citations
17.
Magrioti, Victoria & George Kokotos. (2006). Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 5(2). 189–203. 22 indexed citations
18.
Constantinou‐Kokotou, Violetta, Victoria Magrioti, & Robert Verger. (2004). Sterically Hindered Triacylglycerol Analogues as Potent Inhibitors of Human Digestive Lipases. Chemistry - A European Journal. 10(5). 1133–1140. 7 indexed citations
19.
Magrioti, Victoria, Dimitra Hadjipavlou‐Litina, & Violetta Constantinou‐Kokotou. (2003). Synthesis and In vivo anti-inflammatory activity of long-chain 2-amino-alcohols. Bioorganic & Medicinal Chemistry Letters. 13(3). 375–377. 10 indexed citations
20.
Magrioti, Victoria & Violetta Constantinou‐Kokotou. (2003). Synthesis and use of N , N -di-Boc-glutamate ?-semialdehydes and related aldehydes. Amino Acids. 24(3). 231–243. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026